Thieme E-Books & E-Journals -
Back
CC BY 4.0 · Gesundheitsökonomie & Qualitätsmanagement
DOI: 10.1055/a-2578-0989
Originalarbeit

Die Bedeutung der G-BA Einordnung als „Relevante Therapieoption“ und ihre Auswirkungen auf die Preisverhandlungen

The Significance of the G-BA Assessment “Relevant Treatment Option” and its Impact on Price Negotiations
1   Healthcare Research and Market Access, Digital Health, fbeta GmbH, Berlin, Germany
2   Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
,
3   Health Economics, Market Access & Reimbursement, Janssen-Cilag GmbH, Pharmaceutical Companies of Johnson & Johnson, Neuss, Germany
,
1   Healthcare Research and Market Access, Digital Health, fbeta GmbH, Berlin, Germany
,
3   Health Economics, Market Access & Reimbursement, Janssen-Cilag GmbH, Pharmaceutical Companies of Johnson & Johnson, Neuss, Germany
› Author Affiliations